Tuesday, March 09, 2021 10:43:25 AM
I am going to share with you part of my DD, as well as my impressions of what is going to happen shortly:
1) Yes, as you mentioned really well, the share structure is awesome, with one of the lowest float I've seen in OTC, and it would take just a little volume to send $AMHD to multi-dollar land;
2) I know the company - HLK Biotech is under the umbrella of a conglomerate of companies; they have been in good standing business for over 25 years in Asia;
3) According to my DD, the intention of the company is to be listed in NASDAQ;
3) And here is where things begin to get very interesting: the original shareholders, which held 100M shares, are pressuring the company to move on with the plan, specially now that Trump is no longer the POTUS. Here is the link for the original shareholders disclosure: https://backend.otcmarkets.com/otcapi/company/financial-report/194713/content
And here's another thing: The original shareholders CANNOT sell their shares until the company is current for at least a year, and that's why they have been pressuring the company, because they want to get the return of their investment;
4) Knowing the company business and assets, $AMHD is a $100+ pps;
5) And another reason you mentioned that with a few trades it would send AMHD to dollar land is because shares are very, very scarce - in fact I believe that the shares that have been sold so far are concentrated in the hands of few people, which are not selling because they know what they have in their hands. And the few sales we've seen might be due to lazy sellers who don't know what they have.
That's why we've seen this recent accumulation and consequently the pps has raised a bit. But it's still way far from the real value. Again, this is a multiple hundred dollars stock. And as people usually say, somebody knows something.
And the company better be working on a S-1 by now, because clock is ticking...
Hope this helps and clarifies.
Thank you.
**DISCLOSURE** My posts express my sole opinion. They are not investment advice nor a recommendation regarding any course of action. My opinions are subject to change without notice. Assess investments according to your personal financial circumstances.
FEATURED Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM
Avant Technologies to Revolutionize Data Center Management with Proprietary AI Software Platform • AVAI • May 16, 2024 8:00 AM
HealthLynked Corp Announces First Quarter 2024 Results: Achieves 8% Revenue Growth Over Last Quarter • HLYK • May 16, 2024 8:00 AM